LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, today announced continued advancement of its mobile healthcare application ecosystem, including applications being prepared for anticipated future availability through both the Apple App Store and Google Play Store. The company also reported that its early-stage platform subscribers have surpassed 1,000, which management believes reflects continued early interest and engagement with the LataMed AI healthcare technology ecosystem.
According to the company, the applications currently under development are intended to support various telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare support initiatives as part of its broader digital healthcare infrastructure strategy. Management stated that development, testing, integration, and platform optimization efforts are ongoing for multiple mobile healthcare applications aimed at improving healthcare accessibility and coordination in emerging markets, particularly Latin America.
The company further stated that certain applications are being prepared for anticipated future submission and availability through the Apple App Store and Google Play Store following continued development, internal testing, platform review processes, and applicable regulatory considerations. No assurance can be provided regarding the timing of any public release or commercial availability.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives.”
The company emphasized that the applications and related platform technologies remain under active development and have not yet been fully commercialized or broadly deployed. LataMed AI noted that its broader technology initiatives remain focused on scalable healthcare infrastructure solutions intended to support underserved and developing markets where access to healthcare coordination, telehealth services, and digital healthcare tools may be limited or fragmented.
For more information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
